Targeting Nucleolin By RNA G-Quadruplex-Forming Motif.

Jean-Louis Mergny , Carla Cruz , Josué Carvalho , André Miranda
Biochemical Pharmacology 114418 -114418

1
2021
Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review.

Bernardo Bonanni , Carlo La Vecchia , Sara Gandini , Francesca Magnoni
Cancers 13 ( 6) 1269

1
2021
Dependence of Tensional Homeostasis on Cell Type and on Cell–Cell Interactions

Alicia J. Zollinger , Han Xu , Joana Figueiredo , Joana Paredes
Cellular and Molecular Bioengineering 11 ( 3) 175 -184

10
2018
Targeting XIAP for Chemosensitization Purposes: Different Effect with Different Cytotoxic Drugs.

Hugo Seca , Liliana Santos , Joana Figueiredo , Raquel T Lima
Blood 112 ( 11) 1597 -1597

2008
Epithelial E- and P-cadherins: Role and clinical significance in cancer

Joana Caldeira , Ângela Margarida Costa , Joana Simões-Correia , Maria José Oliveira
Biochimica et Biophysica Acta 1826 ( 2) 297 -311

145
2012
E-Cadherin Destabilization Accounts for the Pathogenicity of Missense Mutations in Hereditary Diffuse Gastric Cancer

Joana Simões-Correia , Joana Figueiredo , Rui Lopes , François Stricher
PLoS ONE 7 ( 3) e33783

49
2012
Corrigendum: Quantification of topological features in cell meshes to explore E-cadherin dysfunction

Tânia Mestre , Joana Figueiredo , Ana Sofia Ribeiro , Joana Paredes
Scientific Reports 6 ( 1) 30222 -30222

2016
CDH1‐related hereditary diffuse gastric cancer syndrome: Clinical variations and implications for counseling

Irma Kluijt , Ester J.M. Siemerink , Margreet G.E.M. Ausems , Theo A.M. van Os
International Journal of Cancer 131 ( 2) 367 -376

84
2012
Hereditary diffuse gastric cancer: updated clinical practice guidelines.

Vanessa R Blair , Maybelle McLeod , Fátima Carneiro , Daniel G Coit
Lancet Oncology 21 ( 8)

185
2020
E-cadherin mediated cellular effects and molecular partners. Gastric cancer as an invasive model

Joana Figueiredo , Joana Simões-Correia , Joana Fernandes , Ana R Mateus
BMC Proceedings 4 ( 2) 1 -1

2010
23
2009
Therapeutic targets associated to E-cadherin dysfunction in gastric cancer.

Patrícia Carneiro , Joana Figueiredo , Renata Bordeira-Carriço , Maria Sofia Fernandes
Expert Opinion on Therapeutic Targets 17 ( 10) 1187 -1201

21
2013
A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation.

Ana Preto , Cátia Moutinho , Sérgia Velho , Carla Oliveira
Virchows Archiv 450 ( 6) 619 -626

12
2007
Quantification of topological features in cell meshes to explore E-cadherin dysfunction.

Tânia Mestre , Joana Figueiredo , Ana Sofia Ribeiro , Joana Paredes
Scientific Reports 6 ( 1) 25101 -25101

11
2016
The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC

Joana Figueiredo , Ola Söderberg , Joana Simões-Correia , Karin Grannas
European Journal of Human Genetics 21 ( 3) 301 -309

56
2013
E-cadherin mutations and cell motility: a genotype-phenotype correlation

Ana Rita Mateus , Joana Simões-Correia , Joana Figueiredo , Stefan Heindl
Experimental Cell Research 315 ( 8) 1393 -1402

75
2009
Clinical and functional characterization of the CDH1 germline variant c.1679C>G in three unrelated families with hereditary diffuse gastric cancer

Laura Pena-Couso , José Perea , Soraia Melo , Fátima Mercadillo
European Journal of Human Genetics 26 ( 9) 1348 -1353

5
2018
E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.

Carla Oliveira , Hugo Pinheiro , Joana Figueiredo , Raquel Seruca
Progress in Molecular Biology and Translational Science 116 337 -359

61
2013
Predicting the Functional Impact of CDH1 Missense Mutations in Hereditary Diffuse Gastric Cancer.

Soraia Melo , Joana Figueiredo , Maria Fernandes , Margarida Gonçalves
International Journal of Molecular Sciences 18 ( 12) 2687

22
2017